Education
About Us
Working with TipRanks
Follow Us
Sartorius Stedim Biotech (GB:0RG8)
LSE:0RG8
RESEARCH TOOLSreports
0RG8 Analyst Ratings
Strong Buy
6 Buy
2 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
0RG8 Stock 12 Month Forecast
Average Price Target
€227.38
▲(30.30% Upside)
| Highest Price Target€240.00 | Average Price Target€227.38 | Lowest Price Target€210.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Jefferies
€245→€229
Buy
31.23%
Upside
Reiterated
08/12/25
TR | OpenAI - 4o
€180→€174
Hold
-0.29%
Downside
Reiterated
08/06/25
Barclays
€250→€240
Buy
37.54%
Upside
Reiterated
07/23/25
J.P. Morgan
€230→€225
Buy
28.94%
Upside
Reiterated
07/23/25
RBC Capital
€240→€230
Buy
31.81%
Upside
Upgraded
07/23/25
Goldman Sachs
€234→€232
Buy
32.95%
Upside
Reiterated
07/23/25
Kepler Capital
€210
Hold
20.34%
Upside
Reiterated
07/22/25
UBS
€220
Hold
26.07%
Upside
Reiterated
07/08/25
Exane BNP Paribas
€233
Buy
33.52%
Upside
Initiated
05/29/25
Morgan Stanley
€260→€250
Buy
43.27%
Upside
Reiterated
04/22/25
Bernstein
€234
Hold
34.10%
Upside
Reiterated
04/16/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Jefferies
€245→€229
Buy
31.23%
Upside
Reiterated
08/12/25
TR | OpenAI - 4o
€180→€174
Hold
-0.29%
Downside
Reiterated
08/06/25
Barclays
€250→€240
Buy
37.54%
Upside
Reiterated
07/23/25
J.P. Morgan
€230→€225
Buy
28.94%
Upside
Reiterated
07/23/25
RBC Capital
€240→€230
Buy
31.81%
Upside
Upgraded
07/23/25
Goldman Sachs
€234→€232
Buy
32.95%
Upside
Reiterated
07/23/25
Kepler Capital
€210
Hold
20.34%
Upside
Reiterated
07/22/25
UBS
€220
Hold
26.07%
Upside
Reiterated
07/08/25
Exane BNP Paribas
€233
Buy
33.52%
Upside
Initiated
05/29/25
Morgan Stanley
€260→€250
Buy
43.27%
Upside
Reiterated
04/22/25
Bernstein
€234
Hold
34.10%
Upside
Reiterated
04/16/25
Best Analysts Covering Sartorius Stedim Biotech
1 Month
xxx
Success Rate
5/8 ratings generated profit
Average Return
+1.25%
initiated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 62.50% of your transactions generating a profit, with an average return of +1.25% per trade.
3 Months
xxx
Success Rate
10/18 ratings generated profit
Average Return
+1.53%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 55.56% of your transactions generating a profit, with an average return of +1.53% per trade.
1 Year
Success Rate
5/18 ratings generated profit
Average Return
-9.46%
reiterated a buy rating last month
Copying Richard Vosser's trades and holding each position for 1 Year would result in 27.78% of your transactions generating a profit, with an average return of -9.46% per trade.
2 Years
xxx
Success Rate
2/10 ratings generated profit
Average Return
-14.20%
reiterated a xxx
rating 17 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 20.00% of your transactions generating a profit, with an average return of -14.20% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
0RG8 Analyst Recommendation Trends
Rating
Apr 25
May 25
Jun 25
Jul 25
Aug 25
Strong Buy
0
0
0
0
0
Buy
16
13
9
7
6
Hold
9
6
10
11
11
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
25
19
19
18
17
Each month's total comprises the sum of three months' worth of ratings.
0RG8 Financial Forecast
0RG8 Stock Forecast FAQ
What is GB:0RG8’s average 12-month price target, according to analysts?
Based on analyst ratings, Sartorius Stedim Biotech’s 12-month average price target is 227.38.
What is GB:0RG8’s upside potential, based on the analysts’ average price target?
Sartorius Stedim Biotech has 30.30% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Sartorius Stedim Biotech a Buy, Sell or Hold?
Sartorius Stedim Biotech has a consensus rating of Strong Buy, which is based on 6 buy ratings, 2 hold ratings and 0 sell ratings.
What is Sartorius Stedim Biotech’s share price target?
The average share price target for Sartorius Stedim Biotech is 227.38. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €240.00 ,and the lowest forecast is €210.00. The average share price target represents 30.30% Increase from the current price of €174.5.
The highest analyst share price target is €240.00 ,and the lowest forecast is €210.00. The average share price target represents 30.30% Increase from the current price of €174.5.
What do analysts say about Sartorius Stedim Biotech?
Sartorius Stedim Biotech’s analyst rating consensus is a Strong Buy. This is based on the ratings of 8 Wall Streets Analysts.
How can I buy shares of Sartorius Stedim Biotech?
To buy shares of GB:0RG8, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.